Anika Therapeutics ANIK Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's operating lease ROU assets?
- Anika Therapeutics (ANIK) reported operating lease ROU assets of $25.43M in Q1 2026.
- How has Anika Therapeutics's operating lease ROU assets changed year-over-year?
- Anika Therapeutics's operating lease ROU assets increased by 1.0% year-over-year, from $25.18M to $25.43M.
- What is the long-term trend for Anika Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Anika Therapeutics's operating lease ROU assets has grown at a 2.8% compound annual growth rate (CAGR), from $22.62M to $25.94M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.